This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Beijing Chengyi Investment Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Xuexiang Cheng: Innovator in Eye Health Solutions
Introduction
Xuexiang Cheng is a notable inventor based in Beijing, China. He has made significant contributions to the field of medicine, particularly in the area of eye health. His innovative work focuses on the use of specific compounds to protect and treat eye injuries.
Latest Patents
Xuexiang Cheng holds a patent for the use of luteolin-7-O-glucoside or luteolin-7-O-glucuronide in the preparation of medicine for eye injuries. This patent highlights the application of these compounds in treating eye injuries caused by blue light. The research demonstrates that luteolin-7-O-glucoside and luteolin-7-O-glucuronide effectively protect retinal pigment epithelial cells from damage induced by blue light. This discovery opens avenues for developing eye-protection health products and foods.
Career Highlights
Cheng is associated with Beijing Chengyi Investment Co., Ltd., where he continues to advance his research and innovations. His work has garnered attention for its potential impact on eye health and safety.
Collaborations
Cheng collaborates with Hao Wang, contributing to the development of innovative solutions in the medical field.
Conclusion
Xuexiang Cheng's contributions to eye health through his patented innovations demonstrate the importance of research in developing effective treatments for eye injuries. His work is paving the way for future advancements in medical solutions for eye protection.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile